Basic Information
LncRNA/CircRNA Name | SNHG7 |
Synonyms | SNHG7, NCRNA00061 |
Region | GRCh38_9:136721366-136728184 |
Ensemble | ENSG00000233016 |
Refseq | NR_003672 |
Classification Information
Regulatory Mechanism | Biological Function | Clinical Application | |||
---|---|---|---|---|---|
TF | Immune | Survival | |||
Enhancer | Apoptosis | apoptosis | Drug | ||
Variant | Cell Growth | Circulating | |||
MiRNA | EMT | Metastasis | |||
Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
Cancer Name | colorectal cancer |
ICD-0-3 | C19.9 |
Methods | Microarray, qPCR, RIP, Luciferase reporter assay, Western blot, etc. |
Sample | CRC cell lines (caco2, SW480, SW620, Hct116, LoVo). human normal colon epithelial cell line (FHC). CRC tissues, adjacent tissues. |
Expression Pattern | down-regulation |
Function Description | SNHG7 expression showed a high fold (SW620/SW480) in CRC microarrays. The CRC patients with high expression of SNHG7 had a significantly poor prognosis. Furthermore, SNHG7 promoted CRC cell proliferation, metastasis, mediated cell cycle, and inhibited apoptosis. SNHG7 and GALNT7 were observed for co-expression by CNC analysis, and a negative correlation of SNHG7 and miR-34a were found by competing endogenous RNA (ceRNA) analysis. The CRC-related SNHG7 and miR-34a might be implicated in CRC progression via GALNT7, suggesting the potential usage of SNHG7/miR-34a/GALNT7 axis in CRC treatment.The survival curves were calculated using the Kaplan-Meier method, and the differences were assessed by a log-rank test. |
Pubmed ID | 29970122 |
Year | 2018 |
Title | Long non-coding RNA-SNHG7 acts as a target of miR-34a to increase GALNT7 level and regulate PI3K/Akt/mTOR pathway in colorectal cancer progression. |
External Links
Links for SNHG7 | GenBank HGNC NONCODE |
Links for colorectal cancer | OMIM COSMIC |